The company expects next quarter to read out initial data from its Heart-2 trial, which is testing a one-time treatment for people with genetically elevated cholesterol.

Jim Cramer, host of Mad Money, expressed his frustration on March 19 about how investors often get caught up in discussions ...

GoodRx is a top small-cap value stock pick with strong EBITDA, new strategic leadership, and promising growth projected for ...

In Harrington v. Purdue Pharma L.P., the Supreme Court held that the Bankruptcy Code does not authorize a bankruptcy court to ...

The biotech company, focused on developing treatments for chronic eye conditions, received Food and Drug Administration (FDA) ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

Johnson & Johnson (JNJ) will make over $55 billion worth of investments across various healthcare sectors in the U.S. during ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Pharmaceuticals industry for Monday, March 24, 2025. Let’s take ...

We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. In this article, we are going to take a look at where Charles River Laboratories International, Inc.

Me filed for bankruptcy on Sunday, hit by faltering demand for its ancestry testing kits as it struggled to contain the ...

The big biotech signed a 15-year lease for approximately 580,000-square-feet of space in “Kendall Commons,” a development project spearheaded by MIT.

Harmony Biosciences has named Adam Zaeske its next chief commercial officer, luring the Takeda veteran back from Europe to ...